40,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Stroke is a leading cause of death in developed countries. However,current therapeutic strategies for stroke have been largelyunsuccessful. One possible explanation is that research andpharmacological management have focused on very early events in brainischemia. New research has shown that brain ischemia and trauma elicitstrong inflammatory reactions driven by both external and brain cells.The recognition of inflammation as a fundamental response to brainischemia provides novel opportunities for new anti-inflammatorytherapies.For the first time, an international body of researchers presents…mehr

Produktbeschreibung
Stroke is a leading cause of death in developed countries. However,current therapeutic strategies for stroke have been largelyunsuccessful. One possible explanation is that research andpharmacological management have focused on very early events in brainischemia. New research has shown that brain ischemia and trauma elicitstrong inflammatory reactions driven by both external and brain cells.The recognition of inflammation as a fundamental response to brainischemia provides novel opportunities for new anti-inflammatorytherapies.For the first time, an international body of researchers presents thelatest findings about the cellular and humoral aspects of immune andinflammatory reactions in the brain. The work may have an impact on thetreatment of neuroinjuries and ancillary brain diseases, and increasethe understanding of the roles infections and immune reactions play inthe brain milieu.